145 related articles for article (PubMed ID: 6606302)
1. Preclinical evaluation of lentinan in animal models.
Chihara G
Adv Exp Med Biol; 1983; 166():189-97. PubMed ID: 6606302
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
Suga T; Shiio T; Maeda YY; Chihara G
Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
Chihara G
Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
[TBL] [Abstract][Full Text] [Related]
4. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
[TBL] [Abstract][Full Text] [Related]
5. Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors.
Abe S; Yoshioka O; Masuko Y; Tsubouchi J; Kohno M; Nakajima H; Yamazaki M; Mizono D
Gan; 1982 Feb; 73(1):91-6. PubMed ID: 6749591
[TBL] [Abstract][Full Text] [Related]
6. Current status and perspectives of immunomodulators of microbial origin.
Chihara G; Maeda YY; Hamuro J
Int J Tissue React; 1982; 4(3):207-25. PubMed ID: 6815071
[TBL] [Abstract][Full Text] [Related]
7. Beta (1-3) glucans as a probe for T cell specific immune adjuvants. II. Enhanced in vitro generation of cytotoxic T lymphocytes.
Hamuro J; Wagner H; Röllinghoff M
Cell Immunol; 1978 Jul; 38(2):328-35. PubMed ID: 307986
[No Abstract] [Full Text] [Related]
8. [Age-dependent anti-tumor activity of lentinan in mice].
Shiio T; Yoshihama T; Tsuchiya Y; Yugari Y
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2300-4. PubMed ID: 3606149
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
Moriya N; Miwa H; Taketsuka S; Orita K
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308
[TBL] [Abstract][Full Text] [Related]
10. Regression induced by lentinan, of peritoneal carcinomatoses in a model of colon cancer in rat.
Jeannin JF; Lagadec P; Pelletier H; Reisser D; Olsson NO; Chihara G; Martin F
Int J Immunopharmacol; 1988; 10(7):855-61. PubMed ID: 3235240
[TBL] [Abstract][Full Text] [Related]
11. Changes of antitumor immunity of hosts with murine mammary tumors regressed by lentinan: potentiation of antitumor delayed hypersensitivity reaction.
Masuko Y; Nakajima H; Tsubouchi J; Yamazaki M; Mizuno D; Abe S
Gan; 1982 Oct; 73(5):790-7. PubMed ID: 7166231
[TBL] [Abstract][Full Text] [Related]
12. Denaturation and renaturation of a beta-1,6;1,3-glucan, lentinan, associated with expression of T-cell-mediated responses.
Maeda YY; Watanabe ST; Chihara C; Rokutanda M
Cancer Res; 1988 Feb; 48(3):671-5. PubMed ID: 2446749
[TBL] [Abstract][Full Text] [Related]
13. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
Shiio T; Ohishi K; Tsuchiya Y; Niitsu I; Hayashibara H; Yoshihama T; Moriyuki H
Gan To Kagaku Ryoho; 1988 Mar; 15(3):475-9. PubMed ID: 3348633
[TBL] [Abstract][Full Text] [Related]
14. Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts.
Zákány J; Chihara G; Fachet J
Int J Cancer; 1980 Mar; 25(3):371-6. PubMed ID: 7390659
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues.
Hamuro J; Röllinghoff M; Wagner H
Immunology; 1980 Apr; 39(4):551-9. PubMed ID: 6966608
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide.
Abe S; Tsubouchi J; Takahashi K; Yamazaki M; Mizuno D
Gan; 1982 Dec; 73(6):961-7. PubMed ID: 7160585
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of lentinan on neoplastic diseases.
Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Ogawa N
Adv Exp Med Biol; 1983; 166():181-7. PubMed ID: 6650280
[No Abstract] [Full Text] [Related]
18. [Potentiation of combination effect of cisplatin and radiation--application of biological response modifiers].
Egawa S; Kadowaki K; Ishibashi A; Komiyama K; Umezawa I
Nihon Hinyokika Gakkai Zasshi; 1989 Feb; 80(2):249-55. PubMed ID: 2747088
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan.
Rose WC; Reed FC; Siminoff P; Bradner WT
Cancer Res; 1984 Apr; 44(4):1368-73. PubMed ID: 6704958
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation and consideration of BRM-BRM and HDP (host defense potentiators)].
Chihara G
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1588-96. PubMed ID: 3382231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
